Submission Details
| 510(k) Number | K234053 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 22, 2023 |
| Decision Date | August 09, 2024 |
| Days to Decision | 231 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K234053 is an FDA 510(k) clearance for the F&P Optiflow Flow Diverter, a Valve, Non-rebreathing (Class II — Special Controls, product code CBP), submitted by Fisher &Paykel Healthcare , Ltd. (Auckland, NZ). The FDA issued a Cleared decision on August 9, 2024, 231 days after receiving the submission on December 22, 2023. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5870.
| 510(k) Number | K234053 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 22, 2023 |
| Decision Date | August 09, 2024 |
| Days to Decision | 231 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | CBP — Valve, Non-rebreathing |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5870 |